Showing results (2251-2260 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|November 28, 2024
Fracture-Related Safety Reporting of JAK Inhibitors: An Analysis from the WHO Global VigiBaseAdrian Martinez de la Torre, Andreas Bech Clausen, Andrea M Burden, et al.Drug Safety|November 21, 2024
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case StudyMathias Møllebæk, Helga Gardarsdottir, Alexia-Georgia Bikou, et al.Drug Safety|March 20, 2025
Mitigation and Management of Common Toxicities Associated with the Administration of CAR-T Therapies in Oncology PatientsJonathan Renninger, Lisa Kurz, Heather SteinDrug Safety|September 12, 2024
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied WorldwideCorine Ekhart, Sjoerd H P Wiarda, Sonja van de Koppel, et al.Drug Safety|September 3, 2024
Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled TrialsShih-Hao Cheng, William Chu, Wen-Hsiang Chou, et al.Drug Safety|July 16, 2024
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist"Lykke Skaarup, Elvina Ingrid, Alexandre Sepriano, et al.Drug Safety|July 31, 2024
Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA LabelingGeorge A Neyarapally, Leihong Wu, Joshua Xu, et al.Drug Safety|July 27, 2024
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series StudyCristina Morciano, Marco Massari, Maria Cutillo, et al.Drug Safety|August 15, 2024
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting SystemMichele Fusaroli, Stefano Polizzi, Luca Menestrina, et al.Drug Safety|August 17, 2024
Caveats of Covariate Adjustment in Disproportionality Analysis for Best PracticesYoshihiro Noguchi, Tomoya Tachi, Tomoaki YoshimuraPageof 311